{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:30:13Z","timestamp":1793241013396,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800204"],"award-info":[{"award-number":["81800204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.biopha.2020.110114","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T16:56:09Z","timestamp":1586969769000},"page":"110114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Recent advances in the molecular mechanism of thalidomide teratogenicity"],"prefix":"10.1016","volume":"127","author":[{"given":"Shaobing","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2020.110114_bib0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/tera.1420380303","article-title":"A short history of thalidomide embryopathy","volume":"38","author":"Lenz","year":"1988","journal-title":"Teratology"},{"issue":"2","key":"10.1016\/j.biopha.2020.110114_bib0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/bdrc.21096","article-title":"Thalidomide-induced teratogenesis: history and mechanisms","volume":"105","author":"Vargesson","year":"2015","journal-title":"Birth Defects Res. C Embryo Today"},{"issue":"7216","key":"10.1016\/j.biopha.2020.110114_bib0015","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(61)90927-8","article-title":"Thalidomide and congenital abnormalities","volume":"278","author":"Mcbride","year":"1961","journal-title":"Lancet"},{"issue":"7219","key":"10.1016\/j.biopha.2020.110114_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(62)92665-X","article-title":"Thalidomide and congenital abnormalities","volume":"279","author":"Lenz","year":"1962","journal-title":"Lancet"},{"issue":"7235","key":"10.1016\/j.biopha.2020.110114_bib0025","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(62)91943-8","article-title":"Thalidomide and congenital abnormalities","volume":"1","author":"Somers","year":"1962","journal-title":"Lancet"},{"issue":"7224","key":"10.1016\/j.biopha.2020.110114_bib0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(62)91248-5","article-title":"Thalidomide and congenital abnormalities","volume":"1","author":"Speirs","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2020.110114_bib0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the treatment of Lepra reactions","volume":"6","author":"Sheskin","year":"1965","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2020.110114_bib0040","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.biopha.2020.110114_bib0045","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1084\/jem.187.11.1885","article-title":"Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset","volume":"187","author":"Haslett","year":"1998","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110114_bib0050","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","article-title":"Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha","volume":"163","author":"Corral","year":"1999","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110114_bib0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1182\/blood.V98.1.210","article-title":"Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma","volume":"98","author":"Davies","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.biopha.2020.110114_bib0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.2004.05286.x","article-title":"Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application","volume":"128","author":"Hayashi","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110114_bib0065","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D\u2019Amato","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"21","key":"10.1016\/j.biopha.2020.110114_bib0070","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma","volume":"341","author":"Singhal","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.biopha.2020.110114_bib0075","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa070594","article-title":"Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma","volume":"357","author":"Dimopoulos","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.biopha.2020.110114_bib0080","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1200\/JCO.2004.10.052","article-title":"Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma","volume":"22","author":"Schey","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110114_bib0085","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa041668","article-title":"Efficacy of lenalidomide in myelodysplastic syndromes","volume":"352","author":"List","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.biopha.2020.110114_bib0090","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa061292","article-title":"Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion","volume":"355","author":"List","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2020.110114_bib0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2141.2009.07626.x","article-title":"Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma","volume":"145","author":"Habermann","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110114_bib0100","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1470-2045(06)70723-9","article-title":"Immunomodulating drugs for chronic lymphocytic leukaemia","volume":"7","author":"Chanan-Khan","year":"2006","journal-title":"Lancet Oncol."},{"issue":"5971","key":"10.1016\/j.biopha.2020.110114_bib0105","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","article-title":"Identification of a primary target of thalidomide teratogenicity","volume":"327","author":"Ito","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biopha.2020.110114_bib0110","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF00338341","article-title":"Die sensible phase bei der thalidomid-embryopathie","volume":"1","author":"Nowack","year":"1965","journal-title":"Humangenetik"},{"issue":"5","key":"10.1016\/j.biopha.2020.110114_bib0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y","article-title":"Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses","volume":"60","author":"Miller","year":"1999","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110114_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: the tragedy of birth defects and the effective treatment of disease","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2020.110114_bib0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/tera.10083","article-title":"Offspring of male and female parents with thalidomide embryopathy: birth defects and functional anomalies","volume":"66","author":"Stromland","year":"2002","journal-title":"Teratology"},{"issue":"8","key":"10.1016\/j.biopha.2020.110114_bib0130","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/bdra.20050","article-title":"Mutations in SALL4 in malformed father and daughter postulated previously due to reflect mutagenesis by thalidomide","volume":"70","author":"Kohlhase","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"key":"10.1016\/j.biopha.2020.110114_bib0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0041-008X(65)90095-5","article-title":"Teratogenic effects of thalidomide in rabbits, rats, hamsters, and mice","volume":"7","author":"Fratta","year":"1965","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110114_bib0140","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF00295758","article-title":"Teratologic studies on the Himalayan rabbit: new aspects of thalidomide-induced teratogenesis","volume":"60","author":"Sterz","year":"1987","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110114_bib0145","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/tera.1420160313","article-title":"Non-confirmation of thalidomide induced teratogenesis in rats and mice","volume":"16","author":"Scott","year":"1977","journal-title":"Teratology"},{"key":"10.1016\/j.biopha.2020.110114_bib0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2121-7-17","article-title":"Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells","volume":"7","author":"Tamilarasan","year":"2006","journal-title":"BMC Cell Biol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110114_bib0155","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1476-5381.2009.00446.x","article-title":"Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase","volume":"158","author":"Majumder","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110114_bib0160","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/srep00679","article-title":"Nitric oxide rescues thalidomide mediated teratogenicity","volume":"2","author":"Siamwala","year":"2012","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2020.110114_bib0165","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2174\/138920006778017777","article-title":"Thalidomide metabolism and hydrolysis: mechanisms and implications","volume":"7","author":"Lepper","year":"2006","journal-title":"Curr. Drug Metab."},{"issue":"21","key":"10.1016\/j.biopha.2020.110114_bib0170","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0901505106","article-title":"Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation","volume":"106","author":"Therapontos","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.biopha.2020.110114_bib0175","doi-asserted-by":"crossref","first-page":"33237","DOI":"10.18632\/oncotarget.8909","article-title":"In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems","volume":"7","author":"Beedie","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2020.110114_bib0180","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/8466","article-title":"Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity","volume":"5","author":"Parman","year":"1999","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110114_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/152308604771978291","article-title":"A novel hypothesis for thalidomide-induced limb teratogenesis: redox misregulation of the NF-kappaB pathway","volume":"6","author":"Hansen","year":"2004","journal-title":"Antioxid. Redox Signal."},{"issue":"12","key":"10.1016\/j.biopha.2020.110114_bib0190","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/bies.200900103","article-title":"Thalidomide-induced limb defects: resolving a 50-year-old puzzle","volume":"31","author":"Vargesson","year":"2009","journal-title":"Bioessays"},{"issue":"11","key":"10.1016\/j.biopha.2020.110114_bib0195","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tibs.2009.07.002","article-title":"CRL4s: the CUL4-RING E3 ubiquitin ligases","volume":"34","author":"Jackson","year":"2009","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2020.110114_bib0200","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbcan.2018.11.007","article-title":"The emerging role for Cullin 4 family of E3 ligases in tumorigenesis","volume":"1871","author":"Cheng","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2020.110114_bib0205","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2337\/db12-1030","article-title":"Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice","volume":"62","author":"Lee","year":"2013","journal-title":"Diabetes"},{"issue":"18","key":"10.1016\/j.biopha.2020.110114_bib0210","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2011-05-356063","article-title":"Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide","volume":"118","author":"Zhu","year":"2011","journal-title":"Blood"},{"issue":"6168","key":"10.1016\/j.biopha.2020.110114_bib0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science."},{"issue":"6168","key":"10.1016\/j.biopha.2020.110114_bib0220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kronke","year":"2014","journal-title":"Science."},{"issue":"7559","key":"10.1016\/j.biopha.2020.110114_bib0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature14610","article-title":"Lenalidomide induces ubiquitination and degradation of CK1alpha in del(5q) MDS","volume":"523","author":"Kronke","year":"2015","journal-title":"Nature."},{"key":"10.1016\/j.biopha.2020.110114_bib0230","doi-asserted-by":"crossref","first-page":"15398","DOI":"10.1038\/ncomms15398","article-title":"pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4(CRBN) ubiquitin ligase","volume":"8","author":"An","year":"2017","journal-title":"Nat. Commun."},{"issue":"7512","key":"10.1016\/j.biopha.2020.110114_bib0235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","article-title":"Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide","volume":"512","author":"Fischer","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.biopha.2020.110114_bib0240","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nsmb.2874","article-title":"Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs","volume":"21","author":"Chamberlain","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7597","key":"10.1016\/j.biopha.2020.110114_bib0245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1alpha degradation by the CRL4 ubiquitin ligase","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"issue":"6414","key":"10.1016\/j.biopha.2020.110114_bib0250","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat0572","article-title":"Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN","volume":"362","author":"Sievers","year":"2018","journal-title":"Science."},{"key":"10.1016\/j.biopha.2020.110114_bib0255","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38430","article-title":"Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome","volume":"7","author":"Donovan","year":"2018","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.biopha.2020.110114_bib0260","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000071048","article-title":"Cloning and expression analysis of SALL4, the murine homologue of the gene mutated in Okihiro syndrome","volume":"98","author":"Kohlhase","year":"2002","journal-title":"Cytogenet. Genome Res."},{"issue":"2","key":"10.1016\/j.biopha.2020.110114_bib0265","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ydbio.2006.02.009","article-title":"The vertebrate spalt genes in development and disease","volume":"293","author":"Sweetman","year":"2006","journal-title":"Dev. Biol."},{"issue":"50","key":"10.1016\/j.biopha.2020.110114_bib0270","doi-asserted-by":"crossref","first-page":"19756","DOI":"10.1073\/pnas.0809321105","article-title":"Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells","volume":"105","author":"Yang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biopha.2020.110114_bib0275","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13045-017-0531-y","article-title":"The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis","volume":"10","author":"Yang","year":"2017","journal-title":"J. Hematol. Oncol."},{"issue":"16","key":"10.1016\/j.biopha.2020.110114_bib0280","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1073\/pnas.1421949112","article-title":"Sall4-Gli3 system in early limb progenitors is essential for the development of limb skeletal elements","volume":"112","author":"Akiyama","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.biopha.2020.110114_bib0285","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1086\/343821","article-title":"Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family","volume":"71","author":"Al-Baradie","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"23","key":"10.1016\/j.biopha.2020.110114_bib0290","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1093\/hmg\/11.23.2979","article-title":"Okihiro syndrome is caused by SALL4 mutations","volume":"11","author":"Kohlhase","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2020.110114_bib0295","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/376436","article-title":"Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype","volume":"73","author":"Brassington","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.biopha.2020.110114_bib0300","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jmg.40.7.473","article-title":"Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy","volume":"40","author":"Kohlhase","year":"2003","journal-title":"J. Med. Genet."},{"issue":"15","key":"10.1016\/j.biopha.2020.110114_bib0305","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1242\/dev.02457","article-title":"The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development","volume":"133","author":"Sakaki-Yumoto","year":"2006","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.biopha.2020.110114_bib0310","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng1707","article-title":"Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart","volume":"38","author":"Koshiba-Takeuchi","year":"2006","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.biopha.2020.110114_bib0315","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1136\/jmg.2004.019505","article-title":"Novel mutations in the gene SALL4 provide further evidence for acro-renal-ocular and Okihiro syndromes being allelic entities, and extend the phenotypic spectrum","volume":"41","author":"Borozdin","year":"2004","journal-title":"J. Med. Genet."},{"issue":"9","key":"10.1016\/j.biopha.2020.110114_bib0320","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1136\/jmg.2004.019901","article-title":"SALL4 deletions are a common cause of Okihiro and acro-renal-ocular syndromes and confirm haploinsufficiency as the pathogenic mechanism","volume":"41","author":"Borozdin","year":"2004","journal-title":"J. Med. Genet."},{"issue":"14","key":"10.1016\/j.biopha.2020.110114_bib0325","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood-2018-05-852798","article-title":"Crbn (I391V) is sufficient to confer in vivo sensitivity to thalidomide and its derivatives in mice","volume":"132","author":"Fink","year":"2018","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.biopha.2020.110114_bib0330","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","article-title":"SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate","volume":"14","author":"Matyskiela","year":"2018","journal-title":"Nat. Chem. Biol."},{"issue":"6729","key":"10.1016\/j.biopha.2020.110114_bib0335","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/19531","article-title":"p63 is a p53 homologue required for limb and epidermal morphogenesis","volume":"398","author":"Mills","year":"1999","journal-title":"Nature"},{"issue":"6729","key":"10.1016\/j.biopha.2020.110114_bib0340","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/19539","article-title":"p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development","volume":"398","author":"Yang","year":"1999","journal-title":"Nature."},{"issue":"13","key":"10.1016\/j.biopha.2020.110114_bib0345","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/ajmg.a.31271","article-title":"Pattern of p63 mutations and their phenotypes--update","volume":"140","author":"Rinne","year":"2006","journal-title":"Am. J. Med. Genet. A"},{"issue":"3","key":"10.1016\/j.biopha.2020.110114_bib0350","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4161\/cc.6.3.3796","article-title":"p63-associated disorders","volume":"6","author":"Rinne","year":"2007","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.biopha.2020.110114_bib0355","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1471-4914(01)02260-2","article-title":"Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans","volume":"8","author":"van Bokhoven","year":"2002","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2020.110114_bib0360","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0092-8674(00)81646-3","article-title":"Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome","volume":"99","author":"Celli","year":"1999","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2020.110114_bib0365","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/302972","article-title":"Split-hand\/split-foot malformation is caused by mutations in the p63 gene on 3q27","volume":"67","author":"Ianakiev","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.biopha.2020.110114_bib0370","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/dvdy.24622","article-title":"P63 expression plays a role in developmental rate, embryo size, and local morphogenesis","volume":"247","author":"Boughner","year":"2018","journal-title":"Dev. Dyn."},{"issue":"3","key":"10.1016\/j.biopha.2020.110114_bib0375","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1097-2765(00)80275-0","article-title":"p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities","volume":"2","author":"Yang","year":"1998","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.biopha.2020.110114_bib0380","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.4161\/cc.9.12.12051","article-title":"DeltaNp63 transcriptionally regulates brachyury, a gene with diverse roles in limb development, tumorigenesis and metastasis","volume":"9","author":"Cho","year":"2010","journal-title":"Cell Cycle"},{"issue":"14","key":"10.1016\/j.biopha.2020.110114_bib0385","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1093\/hmg\/ddu096","article-title":"DLX5, FGF8 and the Pin1 isomerase control DeltaNp63alpha protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations","volume":"23","author":"Restelli","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.biopha.2020.110114_bib0390","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1534-5807(02)00166-1","article-title":"A dominant-negative form of p63 is required for epidermal proliferation in zebrafish","volume":"2","author":"Lee","year":"2002","journal-title":"Dev. Cell"},{"issue":"11","key":"10.1016\/j.biopha.2020.110114_bib0395","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/stem.723","article-title":"TAp63 Is Important for Cardiac Differentiation of Embryonic Stem Cells and Heart Development","volume":"29","author":"Rouleau","year":"2011","journal-title":"Stem Cells"},{"issue":"18","key":"10.1016\/j.biopha.2020.110114_bib0400","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1073\/pnas.1214498110","article-title":"Role of p63 and the Notch pathway in cochlea development and sensorineural deafness","volume":"110","author":"Terrinoni","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2020.110114_bib0405","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13909","article-title":"Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level","volume":"5","author":"Coutandin","year":"2016","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.biopha.2020.110114_bib0410","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s41589-019-0366-7","article-title":"p63 is a cereblon substrate involved in thalidomide teratogenicity","volume":"15","author":"Asatsuma-Okumura","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110114_bib0415","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1083\/jcb.201408106","article-title":"Stemness factor Sall4 is required for DNA damage response in embryonic stem cells","volume":"208","author":"Xiong","year":"2015","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110114_bib0420","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.bbrc.2018.06.145","article-title":"SALL4 suppresses reactive oxygen species in pancreatic ductal adenocarcinoma phenotype via FoxM1\/Prx III axis","volume":"503","author":"Huynh","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2020.110114_bib0425","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/bdra.20384","article-title":"New cases of thalidomide embryopathy in Brazil","volume":"79","author":"Schuler-Faccini","year":"2007","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110114_bib0430","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#","article-title":"Thalidomide, a current teratogen in South America","volume":"54","author":"Castilla","year":"1996","journal-title":"Teratology"},{"issue":"9","key":"10.1016\/j.biopha.2020.110114_bib0435","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/bdra.23376","article-title":"Thalidomide embryopathy: Follow-up of cases born between 1959 and 2010","volume":"103","author":"Kowalski","year":"2015","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.biopha.2020.110114_bib0440","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.niox.2013.09.002","article-title":"Polymorphisms in the endothelial nitric oxide synthase gene in thalidomide embryopathy","volume":"35","author":"Vianna","year":"2013","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.biopha.2020.110114_bib0445","doi-asserted-by":"crossref","first-page":"23404","DOI":"10.1038\/srep23404","article-title":"New Findings in eNOS gene and Thalidomide Embryopathy Suggest pre-transcriptional effect variants as susceptibility factors","volume":"6","author":"Kowalski","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2020.110114_bib0450","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.reprotox.2017.01.012","article-title":"Angiogenesis-related genes and thalidomide teratogenesis in humans: an approach on genetic variation and review of past in vitro studies","volume":"70","author":"Kowalski","year":"2017","journal-title":"Reprod. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110114_bib0455","doi-asserted-by":"crossref","first-page":"11413","DOI":"10.1038\/s41598-019-47739-8","article-title":"The role of ESCO2, SALL4 and TBX5 genes in the susceptibility to thalidomide teratogenesis","volume":"9","author":"Gomes","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2020.110114_bib0460","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/bdr2.1163","article-title":"Genetic susceptibility to thalidomide embryopathy in humans: study of candidate development genes","volume":"110","author":"Gomes","year":"2018","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.biopha.2020.110114_bib0465","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biochi.2015.12.013","article-title":"Harvesting clues from genome wide transcriptome analysis for exploring thalidomide mediated anomalies in eye development of chick embryo: nitric oxide rectifies the thalidomide mediated anomalies by swinging back the system to normal transcriptome pattern","volume":"121","author":"Kumar","year":"2016","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.biopha.2020.110114_bib0470","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1021\/acs.chemrestox.7b00199","article-title":"Transcriptomic analysis of thalidomide challenged chick embryo suggests possible link between impaired vasculogenesis and defective organogenesis","volume":"30","author":"Veeriah","year":"2017","journal-title":"Chem. Res. Toxicol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110114_bib0475","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00210-018-1532-2","article-title":"Thalidomide remodels developing heart in chick embryo: discovery of a thalidomide mediated hematoma in heart muscle","volume":"391","author":"Kumar","year":"2018","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"23","key":"10.1016\/j.biopha.2020.110114_bib0480","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2217\/fon-2018-0090","article-title":"Mechanistic insights into the differential effects of thalidomide and lenalidomide in metastatic prostate cancer","volume":"14","author":"Sundaresan","year":"2018","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110114_bib0485","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1753193418805249","article-title":"The teratogenic effects of thalidomide on limbs","volume":"44","author":"Vargesson","year":"2019","journal-title":"J. Hand Surg. Eur. Vol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220303061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220303061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:50:58Z","timestamp":1760097058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220303061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":97,"alternative-id":["S0753332220303061"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110114","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in the molecular mechanism of thalidomide teratogenicity","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110114"}}